Nonpharmacological management of neonatal abstinence syndrome: a review of the literature
| Autor: | Joe Dooley, Len Kelly, Lianne Gerber Finn, Gareth Ryan |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Pediatrics
medicine.medical_specialty business.industry Infant Newborn Opioid-Related Disorders Obstetrics and Gynecology Conservative Treatment Severity of Illness Index Analgesics Opioid 03 medical and health sciences 0302 clinical medicine Neonatal abstinence Opioid Pregnancy 030225 pediatrics Pediatrics Perinatology and Child Health medicine Humans Female 030212 general & internal medicine business Neonatal Abstinence Syndrome medicine.drug |
| Zdroj: | The Journal of Maternal-Fetal & Neonatal Medicine. 32:1735-1740 |
| ISSN: | 1476-4954 1476-7058 |
| DOI: | 10.1080/14767058.2017.1414180 |
| Popis: | Infants with neonatal abstinence syndrome (NAS) experience withdrawal that occurs as a result of termination of placental opioid supply following delivery. Common symptoms include restlessness, tremors, agitation and gastrointestinal disturbances. Severe NAS is often treated using opioids and/or sedatives. Although commonly employed effectively in neonatal care, there is a lack of published information regarding nonpharmacological management of the NAS infant.The purpose of this review was to summarize the current literature on nonpharmacological management of NAS.A literature search of Medline and EMBASE was performed for articles published between 2000 and June 2107.Nonpharmacological management encompasses "environmental control", "feeding methods", "social integration", "soothing techniques" and "therapeutic modalities". Several interventions, including: breastfeeding, swaddling, rooming-in, environmental control and skin to skin contact have proven to be effective in managing NAS and should be incorporated into standard of care for this population (Level I-III Evidence). These interventions can be effective when offered in combination with pharmacological therapy, or as stand-alone therapy for less severe cases of NAS (Finnegan score8).Given the increasing body of evidence on its efficacy and ease of implementation, nonpharmacological treatment should universally be incorporated into standard of care for NAS. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|